PAUL LAURENCE E 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Jun 4, 2012
Insider Transaction Report
Form 4
PAUL LAURENCE E
Director
Transactions
- Award
Common Shares, no par value
2012-06-04+8,062→ 56,159 total
Footnotes (2)
- [F1]Annual grant of Restricted Share Units.
- [F2]This number represents common shares purchased and other equity awards that were previously reported in Table 1.